West Pharmaceutical Services, Inc. (WST) Financials

WST Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 4.1 billion 1.1 billion
Dec. 31, 2025 4.3 billion 1.1 billion
Sept. 30, 2025 4.1 billion 1.1 billion
June 30, 2025 4.0 billion 1.0 billion

WST Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 47.2 million 6.6 million
Dec. 31, 2025 175.0 million 6.7 million
Sept. 30, 2025 133.9 million 8.4 million
June 30, 2025 101.9 million 7.4 million

WST Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 138.8 million
Dec. 31, 2025 132.1 million
Sept. 30, 2025 140.0 million
June 30, 2025 131.8 million

WST Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 521.4 million 294.8 million 113.4 million
Dec. 31, 2025 791.3 million 202.8 million 118.3 million
Sept. 30, 2025 628.5 million 202.7 million 94.9 million
June 30, 2025 509.7 million 202.6 million 100.7 million

WST Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 72.4 million
Dec. 31, 2025 72.7 million
Sept. 30, 2025 72.7 million
June 30, 2025 72.8 million

WST Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 42.7 million 15.8 million 99.5 million -
Dec. 31, 2025 76.1 million 21.8 million 106.5 million -
Sept. 30, 2025 63.3 million 17.1 million 102.7 million -
June 30, 2025 75.2 million 19.1 million 95.9 million -

WST Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 844.9 million 548.5 million
Dec. 31, 2025 805.0 million 501.1 million
Sept. 30, 2025 804.3 million 510.8 million
June 30, 2025 766.2 million 493.0 million

WST Revenue by Segment
Graph available only for paid members. Upgrade to see it.

WST

List: Champions

Price: $358.72

52 week price:
206.80
367.66

Dividend Yield: 0.24%

5-year range yield:
0.17%
0.38%

Forward Dividend Yield: 0.24%

Payout Ratio: 11.36%

Payout Ratio Range:
-416.00%
850.00%

Dividend Per Share: 0.88 USD

Earnings Per Share: 7.47 USD

P/E Ratio: 39.54

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 800100

Ebitda: 85.9 million

Market Capitalization: 25.8 billion

Average Dividend Frequency: 4

Years Paying Dividends: 42

DGR3: 5.34%

DGR5: 5.67%

DGR10: 6.81%

DGR20: 6.93%

Links: